Skip to main navigation Skip to search Skip to main content

A Phase III randomized, active-comparitor-controlled clinical trial to study the safety and efficacy of MK-1986 (tedizolid phosphate) and comparitor, in subjects 3 months to <12 years of age with Acute Bacterial Skin and Skin Structure. . .

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date08/1/17 → 07/31/20

Funding

  • Merck Sharp and Dohme Limited Liability Corporation: $10,000.00